(Updated - April 15, 2025 6:41 AM EDT)

Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.77, $0.19 better than the analyst estimate of $2.58. Revenue for the quarter came in at $21.89 billion versus the consensus estimate of $21.57 billion.

GUIDANCE:

Johnson & Johnson sees FY2025 EPS of $10.50-$10.70, versus the consensus of $10.50. JNJ sees FY2025 operational sales guidance at $92 billion at the midpoint, versus the consensus of $90.3 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

Earnings Guidance Hot Earnings Hot Guidance